Fundz

Eureka Therapeutics, Inc. reported raising $45 Million in an initial SEC Form D filing, from an offering of $45 Million

PRIVATEJan 24, 2020

Amount Raised

$45 Million

$45 Million sold, per SEC Form D (first sale Jan 24, 2020)

Round Type

Venture

Bay Harbor IslandsBiotechnology

Quick answer

Urica Therapeutics raised $45 Million in a funding round, dated January 24, 2020. Urica Therapeutics is based in Bay Harbor Islands, Florida, United States.

How much did Urica Therapeutics raise?
Urica Therapeutics raised $45 Million in a funding round on January 24, 2020.
What does Urica Therapeutics do?
Urica was founded by Fortress Biotech, Inc. (Nasdaq: FBIO).
Where is Urica Therapeutics based and how big is it?
Urica Therapeutics is based in Bay Harbor Islands, Florida, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Urica Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • CollPlant Biotechnologies Ltd raised $4.5M (Seed) on March 9, 2020.
  • HepGene, Inc. raised $25K (Pre-Seed) on March 9, 2020.
  • Pylum Biosciences, Inc. raised $990K (Seed) on March 6, 2020.
  • Verastem Oncology raised $100M on March 6, 2020.
  • OnKure Therapeutics raised $1M (Seed) on March 6, 2020.
  • Eikonoklastes Therapeutics raised $1.1M on March 5, 2020.

Who to call at Urica Therapeutics, and when

A new round usually means Urica Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Urica Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Urica Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Urica Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Urica Therapeutics

Location

1111 KANE CONCOURSE

Bay Harbor Islands, Florida, United States

About

Urica was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Urica Therapeutics, Inc. (“Urica”) is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout and other conditions associated with hyperuricemia. Urica acquired the rights to develop and commercialize Dotinurad, a potentially best-in-class URAT1 inhibitor, in the United States, United Kingdom, European Union, Canada, Middle East and North Africa (MENA) and Turkey from Fuji Yakuhin. Dotinurad has been approved to treat gout and hyperuricemia in Japan and is currently in a Phase 1 clinical trial in the United States.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Urica Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Urica Therapeutics's next move

See what Strategic adds

Urica Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.